|
|
|
| Dosimetric study on middle ear with three whole-brain radiotherapy techniques |
| WU Zhe, WANG Dong, CHEN Xiaomei, MING Zhi, LIU Ke, YAN Jun |
| Department of Oncology, Zigong First People's Hospital, Zigong 643000 China |
|
|
|
|
Abstract Objective This study aims to compare the advantages and disadvantages of the three techniques in improving the target volume dose and protecting the auris media cavity and eustachian tube isthmus region by investigating the dosimetric differences of three whole-brain radiotherapy techniques.Methods Thirty patients with whole brain metastases were randomly selected to design fixed field intensity modulated radiotherapy (ff-IMRT) plan, volumetric arc modulated therapy (VMAT) and three-dimensional conformal radiotherapy (3DCRT) plan, and to meet a 95% PTV prescription dose (40 Gy). The dosimetric parameters and monitor units of the target volume and organ at risk (OAR) in the three groups of treatment plans were compared and analyzed.Results The Conformity Index (CI) of the ff-IMRT plan (0.93 ±0.02) was better than the VMAT plan (0.89 ±0.01) and the 3DCRT plan (0.73 ±0.03), respectively, and the difference was statistically significant (P < 0.05). The Homogeneity Index (HI) of the three plans were ff-IMRT (0.05 ±0.01)、VMAT(0.08 ±0.1) and 3DCRT (0.08 ±0.01), respectively, and the difference was not statistically significant (P > 0.05). The Gradient Index (GI) were ff-IMRT (1.77 ±0.1), VMAT (1.61 ±0.07), 3DCRT (1.39 ±0.08), respectively. The difference was statistically significant (P < 0.05). The monitor units (MU) were ff-IMRT (1551.97 ±85.02), VMAT (303.7 ±24.28) and 3DCRT (226.2 ±2.5), respectively, the difference was statistically significant (P < 0.05). The Dmax of the middle ear of the three plans were ff-IMRT (2557.54 ±477.39) cGy, VMAT (3107.9 ±362.28) cGy, 3DCRT (4055.37 ±71.45) cGy, respectively. The Dmax of the eustachian tube isthmus were ff-IMRT (2425 ±380.4) cGy, VMAT (2902.4 ±526.3) cGy and 3DCRT (3862.7 ±135.9) cGy, the difference were statistically significant (P < 0.05).Conclusion In whole-brain radiotherapy, ff-IMRT and VMAT significantly reduced the dose of the bilateral middle ear cavities and eustachian tube isthmus compared with 3DCRT. VMAT is recommended for WBRT for reducing the number of monitor units significantly.
|
|
Received: 26 December 2020
|
|
|
|
|
|
[1] Korkmaz Kirakli E, Oztekin O. Is hippocampal avoidance during whole-brain radiotherapy risky for patients with small-cell lung cancer?hippocampal metastasis rate and associated risk factors[J]. Technol Cancer Res Treat, 2017, 16(6): 1202-1208. DOI: 10.1177/1533034617742301
[2] 孟曼, 毕金玲, 黄勇. 脑转移瘤全脑放疗疗效与预后相关因素分析[J]. 中国辐射卫生,2019,28(4):458-461, 472. DOI: 10.13491/j.issn.1004-714x.2019.04.030
Meng M, Bi JL, Huang Y. Analysis of factors related to the efficacy and prognosis of brain metastases in whole brain radiotherapy[J]. Chin J Radiol Health, 2019, 28(4): 458-461, 472. DOI: 10.13491/j.issn.1004-714x.2019.04.030
[3] 宋俊韬, 李学源, 聂东. 两种适形放疗技术在肺癌脑转移瘤中的疗效对比[J]. 中国辐射卫生,2016,25(1):104-106. DOI: 10.13491/j.cnki.issn.1004-714x.2016.01.042
Song JT, Li XY, Nie D. Comparative analysis of two methods for 3D-CRT with brain metastases of non-small cell lung cancer[J]. Chin J Radiol Health, 2016, 25(1): 104-106. DOI: 10.13491/j.cnki.issn.1004-714x.2016.01.042
[4] 陈杰, 朱云云, 陈明东, 等. 全脑照射调强放疗和常规放疗剂量学对比[J]. 医疗卫生装备,2016,37(2):109-111. DOI: 10.7687/J.ISSN1003-8868.2016.02.109
Chen J, Zhu YY, Chen MD, et al. Dosimetric comparision of cranial irradiation between intensity-modulated radiotherapy and conventional radiotherapy[J]. Chin Med Equip J, 2016, 37(2): 109-111. DOI: 10.7687/J.ISSN1003-8868.2016.02.109
[5] Upadhya I, Jariwala N, Datar J. Ototoxic effects of irradiation[J]. Indian J Otolaryngol Head Neck Surg, 2011, 63(2): 151-154. DOI: 10.1007/s12070-011-0142-9
[6] 杨建明. 鼻咽癌放疗前后腭帆张肌横截面积的改变与放射性中耳炎的相关性[J]. 山东大学耳鼻喉眼学报,2014,28(1):31-33. DOI: 10.6040/j.issn.1673-3770.0.2013.212
Yang JM. Relationship between radioactive otitis media and changes in cross section area of tensor veli palatine(TVP)muscle after radiotherapy in patients with nasopharyngeal carcinoma[J]. J Otolaryngol Ophthalmol Shandong Univ, 2014, 28(1): 31-33. DOI: 10.6040/j.issn.1673-3770.0.2013.212
[7] Hsin CH, Tseng HC, Lin HP, et al. Post-irradiation otitis media, rhinosinusitis, and their interrelationship in nasopharyngeal carcinoma patients treated by IMRT[J]. Eur Arch Otorhinolaryngol, 2016, 273(2): 471-477. DOI: 10.1007/s00405-015-3518-8
[8] Stoker J, Vora S, Patel A, et al. Advantages of intensity modulated proton therapy during hippocampal avoidance whole brain radiation therapy[J]. Phys Imaging Radiat Oncol, 2018, 8: 28-32. DOI: 10.1016/j.phro.2018.11.001
[9] 单书灿, 欧丹, 韩一旻, 等. 全脑放射治疗海马区保护的剂量学研究[J]. 中国医学物理学杂志,2019,36(5):546-550. DOI: 10.3969/j.issn.1005-202X.2019.05.010
Shan SC, Ou D, Han YM, et al. Dosimetric research on hippocampal-sparing whole brain radiotherapy[J]. Chin J Med Phys, 2019, 36(5): 546-550. DOI: 10.3969/j.issn.1005-202X.2019.05.010
[10] 叶峰. 鼻咽癌调强放疗放射毒性与临床及放射剂量学因素的相关性分析[D]. 广州: 南方医科大学, 2012.
Ye F. Analyses of clinical and dosimetric parameters associated with radiation-induced toxicities in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy[D]. Guangzhou: Southern Medical University, 2012.
[11] Wang SZ, Wang WF, Zhang HY, et al. Analysis of anatomical factors controlling the morbidity of radiation-induced otitis media with effusion[J]. Radiother Oncol, 2007, 85(3): 463-468. DOI: 10.1016/j.radonc.2007.10.007
[12] Wang SZ, Li J, Miyamoto CT, et al. A study of middle ear function in the treatment of nasopharyngeal carcinoma with IMRT technique[J]. Radiother Oncol, 2009, 93(3): 530-533. DOI: 10.1016/j.radonc.2009.09.013
[13] 林浩然, 李郁明, 杨田福, 等. 鼻咽癌放疗并发分泌性中耳炎的临床病理特征及影响因素分析[J]. 临床医学工程,2020,27(7):875-876. DOI: 10.3969/j.issn.1674-4659.2020.07.0875
Lin HR, Li YM, Yang TF, et al. Analysis on the clinicopathological characteristics and influencing factors of nasopharyngeal carcinoma radiotherapy complicated with secretory otitis media[J]. Clin Med Eng, 2020, 27(7): 875-876. DOI: 10.3969/j.issn.1674-4659.2020.07.0875
[14] Akazawa K,Doi H, Ohta S, et al. Relationship between Eustachian tube dysfunction and otitis media with effusion in radiotherapy patients[J]. J Laryngol Otol, 2018, 132(2): 111-116. DOI: 10.1017/S0022215118000014
[15] Pan CC, Eisbruch A, Lee JS, et al. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients[J]. Int J Radiat Oncol Biol Phys, 2005, 61(5): 1393-1402. DOI: 10.1016/j.ijrobp.2004.08.019
[16] Chan SH, Ng WT, Kam KL, et al. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis[J]. Int J Radiat Oncol, 2009, 73(5): 1335-1342. DOI: 10.1016/j.ijrobp.2008.07.034
[17] Jereczek-Fossa BA, Rondi E, Zarowski A, et al. Prospective study on the dose distribution to the acoustic structures during postoperative 3D conformal radiotherapy for parotid tumors: dosimetric and audiometric aspects[J]. Et Al, 2011, 187(6): 350-356. DOI: 10.1007/s00066-011-2170-5
[18] Hitchcock YJ, Tward JD, Szabo A, et al. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients[J]. Int J Radiat Oncol Biol Phys, 2009, 73(3): 779-788. DOI: 10.1016/j.ijrobp.2008.05.040
|
|
|
|
